Next Article in Journal / Special Issue
No Country for Old Worms: A Systematic Review of the Application of C. elegans to Investigate a Bacterial Source of Environmental Neurotoxicity in Parkinson’s Disease
Previous Article in Journal
Partial Least Squares Discriminant Analysis and Bayesian Networks for Metabolomic Prediction of Childhood Asthma
Previous Article in Special Issue
High-Throughput Direct Mass Spectrometry-Based Metabolomics to Characterize Metabolite Fingerprints Associated with Alzheimer’s Disease Pathogenesis
Article

Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology

1
Institute for Global Food Security (IGFS), Queen’s University Belfast, Stranmillis Road, Belfast BT9 6AG, Ireland
2
Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast BT12 6BA, Ireland
3
Dementia Research Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol BS10 5NB, UK
4
Research and Experimental Center, Henan University of Traditional Chinese Medicine, Longzihu University Campus, 156 Jinshui Dong Road, Zhengzhou 450000, China
5
Metabolomics Research, Beaumont Research Institute 3811 W. 13 Mile Road, Royal Oak, MI 48073, USA
6
Metabolomics Research, Oakland University-William Beaumont School of Medicine, Rochester, MI 48309, USA
*
Author to whom correspondence should be addressed.
Metabolites 2018, 8(4), 69; https://doi.org/10.3390/metabo8040069
Received: 10 September 2018 / Revised: 19 October 2018 / Accepted: 25 October 2018 / Published: 26 October 2018
(This article belongs to the Special Issue Metabolomics in Neurodegenerative Disease)
Brain is a lipid-rich tissue, and fatty acids (FAs) play a crucial role in brain function, including neuronal cell growth and development. This study used GC-MS to survey all detectable FAs in the human parietal cortex (Brodmann area 7). These FAs were accurately quantified in 27 cognitively normal age-matched controls, 16 cases of moderate Alzheimer’s disease (AD), 30 severe AD, and 14 dementia with Lewy bodies (DLB). A total of 24 FA species were identified. Multiple comparison procedures, using stepdown permutation tests, noted higher levels of 13 FAs but the majority of changes were in moderate AD and DLB, rather than severe AD. Subjects with moderate AD and DLB pathology exhibited significantly higher levels of a number of FAs (13 FAs and 12 FAs, respectively). These included nervonic, lignoceric, cis-13,16-docosadienoic, arachidonic, cis-11,14,17-eicosatrienoic, erucic, behenic, α-linolenic, stearic, oleic, cis-10-heptanoic, and palmitic acids. The similarities between moderate AD and DLB were quite striking—arachidic acid was the only FA which was higher in moderate AD than control, and was not similarly affected in DLB. Furthermore, there were no significant differences between moderate AD and DLB. The associations between each FA and a number of variables, including diagnosis, age, gender, Aβ plaque load, tau load, and frontal tissue pH, were also investigated. To conclude, the development of AD or DLB pathology affects brain FA composition but, intriguingly, moderate AD neuropathology impacts this to a much greater extent. Post-mortem delay is a potential confounding factor, but the findings here suggest that there could be a more dynamic metabolic response in the earlier stages of the disease pathology. View Full-Text
Keywords: fatty acid; GC-MS; Alzheimer’s disease; dementia with Lewy bodies; metabolomics; lipidomics fatty acid; GC-MS; Alzheimer’s disease; dementia with Lewy bodies; metabolomics; lipidomics
Show Figures

Figure 1

MDPI and ACS Style

Nasaruddin, M.L.; Pan, X.; McGuinness, B.; Passmore, P.; Kehoe, P.G.; Hölscher, C.; Graham, S.F.; Green, B.D. Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology. Metabolites 2018, 8, 69. https://doi.org/10.3390/metabo8040069

AMA Style

Nasaruddin ML, Pan X, McGuinness B, Passmore P, Kehoe PG, Hölscher C, Graham SF, Green BD. Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology. Metabolites. 2018; 8(4):69. https://doi.org/10.3390/metabo8040069

Chicago/Turabian Style

Nasaruddin, Muhammad L., Xiaobei Pan, Bernadette McGuinness, Peter Passmore, Patrick G. Kehoe, Christian Hölscher, Stewart F. Graham, and Brian D. Green 2018. "Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology" Metabolites 8, no. 4: 69. https://doi.org/10.3390/metabo8040069

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop